ECETOC
  • About ECETOC
    • ECETOC at a Glance
    • What we do
    • Structure
      • General Assembly
      • Board of Administration
      • Scientific Committee
      • Secretariat
    • Funding
    • Contact
  • ECETOC Membership
    • ECETOC Membership
    • Member Companies
    • Partnerships
    • #SCIENCECHATS WEBINARS
  • Science Programme
    • Transformational Programmes
    • Task Forces
      • Active task forces
      • Completed task forces
    • Expert Groups
    • Cefic LRI Projects under ECETOC Management
      • Human Health and Exposure Monitoring Teams
      • Environmental Monitoring Teams
  • Tools
    • ECETOC Human Exposure Assessment Tools Database (heatDB)
    • hSSD Tool
    • NanoApp
      • About nanotechnology
    • Targeted Risk Assessment (TRA)
      • Evolution of the TRA
  • Publications
    • Technical Reports
    • Special Reports
    • Workshop Reports
    • Annual Reports
    • Women In Science
    • Archives
  • News
    • New @ ECETOC
    • Videos
  • Events
  • Youth
    • Science Awards
      • Science awards archive
    • Science Grants
Select Page
Special Report 19
  • Pages
    • SUMMARY
    • PREFACE
      • Definitions
    • INTRODUCTION
      • The value of ontologies
      • The need for a developmental toxicity ontology
      • Purpose of this report
    • AOP/ MOA ONTOLOGY CONCEPT DEFINED
    • RESOURCES FOR BUILDING A DEVELOPMENTAL TOXICITY ONTOLOGY
    • APPROACHES TO BUILDING AN AOP/ MOA ONTOLOGY
    • HOW CAN IT BE DONE?
      • Terminology
      • Specification
      • Ontology development
      • Informal ontologies
      • Natural Language Processing (NLP)
      • Gene Networks
    • CHALLENGES TO BUILDING AND APPLYING AN AOP/ MOA ONTOLOGY
      • Maternal factors
      • Potential MIEs and KEs for building AOPs and IATA for Developmental Toxicity
    • CASE STUDIES FOR AOP DEVELOPMENT
      • Role of Retinoic Acid during Embryogenesis
      • Retinoic Acid and Neural Tube Defects
      • Retinoic Acid and (hind) brain development
      • Conclusions on Case Studies on Retinoic Acid
    • USING TOXCAST TO DEVELOP AOPS
    • ABBREVIATIONS
    • BIBLIOGRAPHY
    • MEMBERS OF THE EXPERT GROUP
    • MEMBERS OF THE SCIENTIFIC COMMITTEE
    • MEMBERS OF THE SCIENTIFIC COMMITTEE (cont’d)

HOW CAN IT BE DONE?

©ECETOC 2023 – Disclaimer Privacy Policy CookieS Policy Contact us